PUBLISHER: The Business Research Company | PRODUCT CODE: 2133882
PUBLISHER: The Business Research Company | PRODUCT CODE: 2133882
Weight loss and obesity management refers to a structured process for reducing and controlling body weight, particularly among individuals who are overweight or obese, through dietary changes, physical activity, behavioral therapy, medications, and, in some cases, surgical interventions. The objective is to improve overall health, lower the risk of obesity-related conditions such as type 2 diabetes, cardiovascular disease, and hypertension, and enhance quality of life.
The primary products and services in weight loss and obesity management include drugs, supplements, equipment, and services. Weight control drugs are medications designed to reduce appetite, inhibit fat absorption, or increase metabolism to support medically supervised weight loss. These drugs are categorized into prescribed and over-the-counter (OTC) options. The target age groups include children, adults, and the geriatric population. They are distributed through various channels, such as institutional sales and retail sales, and are used across industries including fitness centers, slimming centers, consulting services, and online weight loss programs.
Tariffs are influencing the weight loss and obesity management market by increasing the cost of imported medical devices, fitness equipment, pharmaceutical ingredients, and digital health infrastructure components. Healthcare providers and wellness centers in North America and Europe are most affected due to their reliance on imported equipment and formulations, while Asia-Pacific faces cost pressures in expanding service delivery. These tariffs are increasing service pricing and limiting access in cost-sensitive markets. However, they are also encouraging domestic manufacturing of equipment, local formulation of supplements and drugs, and regional expansion of digital health platforms to reduce import dependency.
The weight loss and obesity management market research report is one of a series of new reports from The Business Research Company that provides weight loss and obesity management market statistics, including weight loss and obesity management industry global market size, regional shares, competitors with a weight loss and obesity management market share, detailed weight loss and obesity management market segments, market trends and opportunities, and any further data you may need to thrive in the weight loss and obesity management industry. This weight loss and obesity management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The weight loss and obesity management market size has grown strongly in recent years. It will grow from $258.14 billion in 2025 to $280.83 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rising prevalence of obesity-related health conditions, increasing public health awareness initiatives, expansion of fitness and wellness centers, growing acceptance of medical weight management, and availability of diverse weight loss solutions.
The weight loss and obesity management market size is expected to see strong growth in the next few years. It will grow to $385.26 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing adoption of digital therapeutics, rising demand for personalized obesity treatments, expansion of employer-sponsored wellness programs, growing integration of AI-based health analytics, and increased focus on long-term weight maintenance. Major trends in the forecast period include increasing adoption of personalized weight management programs, rising integration of digital health platforms, growing use of data-driven behavioral therapy, expansion of medically supervised weight loss solutions, and greater focus on preventive health outcomes.
The rising awareness about nutrition and healthy lifestyles is expected to propel the growth of the weight loss and obesity management market in the coming years. Nutrition and healthy lifestyles refer to the practice of maintaining a balanced diet and engaging in physical activities that support long-term health. Awareness about nutrition and healthy lifestyles is increasing as the internet and social media provide convenient access to information, tips, and advice, making it easier for people to learn about healthy eating and lifestyle habits. Greater awareness of nutrition and healthy lifestyles supports weight loss and obesity management by helping individuals make informed dietary choices, engage in regular physical activity, and maintain sustainable and healthy habits. For instance, in June 2024, according to the International Food Information Council (IFIC), a US-based non-profit organization, the proportion of Americans who followed a specific diet or eating pattern over the past year remained high at 54%. Most individuals were aiming to increase their protein intake, with interest rising from 59% in 2022 to 67% in 2023, and reaching 71% in 2024. Additionally, about half of consumers were seeking to consume more fresh foods, which are widely regarded as the healthiest food options. Therefore, the rising awareness of healthy eating and dieting behaviors is driving the growth of the weight loss and obesity management market.
Major companies operating in the weight loss and obesity management market are focusing on developing advanced solutions, such as dual incretin GLP-1/GIP receptor agonists, to improve treatment efficacy, support sustained weight reduction, and enhance metabolic outcomes. Dual incretin agonists are medications that simultaneously activate GLP-1 and GIP receptors, helping reduce appetite, slow gastric emptying, and improve insulin sensitivity, potentially providing more potent and durable effects than traditional single-target therapies. For instance, in November 2023, Eli Lilly, a U.S.-based pharmaceutical company, launched Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity. Tirzepatide mimics the activity of two hormones to prolong satiety, suppress hunger, and support clinically significant and sustained weight loss, with convenient once-weekly administration. This therapy represents a significant advancement in obesity care by providing an effective long-term management option for patients.
In August 2023, Eli Lilly and Company, a US-based pharmaceutical company specializing in treatments for diabetes, oncology, immunology, and obesity-related conditions, acquired Versanis Bio for an undisclosed amount. Through this acquisition, Lilly aims to improve patient outcomes in cardiometabolic diseases by strengthening its obesity treatment pipeline with innovative therapeutic options. Versanis Bio Inc. is a US-based biotechnology company specializing in the development of treatments for weight loss and obesity management.
Major companies operating in the weight loss and obesity management market are F. Hoffmann-La Roche Ltd., Medtronic plc, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Apollo Endosurgery Inc., Biocon Limited, WW International Inc., Equinox Holdings Inc., Noom Inc., Jenny Craig Inc., Nutrisystem Inc., Virta Health Corp., Allurion Technologies Inc., Atkins Nutritionals Inc., ReShape Lifesciences Inc., Nalpropion Pharmaceuticals Inc., OptiBiotix Health plc, PRISTYN CARE
North America was the largest region in the weight loss and obesity management market in 2025. The regions covered in the weight loss and obesity management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the weight loss and obesity management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The weight loss and obesity management market consists of revenues earned by entities by providing services such as dietary and nutritional counseling, fitness and exercise programs, behavioral therapy and lifestyle coaching, medical weight loss programs, surgical weight loss procedures, meal replacement and supplement programs, online and app-based coaching services. The market value includes the value of related goods sold by the service provider or included within the service offering. The weight loss and obesity management market also includes sales of dietary supplements, meal replacements, fitness equipment, surgical devices, prescription medications, mobile health apps, and low-calorie food and beverages. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Weight Loss And Obesity Management Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses weight loss and obesity management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for weight loss and obesity management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The weight loss and obesity management market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.